Investigative Urology - Results from #5320

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction - Abstract October 26, 2012

Molecular markers of adrenocortical tumors - Abstract October 26, 2012

PGE2 promotes renal carcinoma cell invasion through activated RalA - Abstract October 26, 2012

The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma - Abstract October 26, 2012

Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells - Abstract October 26, 2012

MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma - Abstract October 26, 2012

Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: Comparative study of Western blot and immunohistochemistry and implications for diagnosis - Abstract October 26, 2012

Inducible nitric oxide synthase and PPARγ are involved in bladder cancer progression - Abstract October 25, 2012

Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: A support for using continuous measurement from SNP-array data - Abstract October 25, 2012

Pathogenic and diagnostic potential of BLCA-1 and BLCA-4 nuclear proteins in urothelial cell carcinoma of human bladder - Abstract October 25, 2012

High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer - Abstract October 25, 2012

Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer - Abstract October 25, 2012

Increased cyclin-dependent kinase 6 expression in bladder cancer - Abstract October 25, 2012

Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer - Abstract October 25, 2012

Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer - Abstract October 25, 2012

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis - Abstract October 24, 2012

Polymorphisms in XPD and hOGG1 and prostate cancer risk: A meta-analysis - Abstract October 24, 2012

Prostate stem cell antigen-targeted nanoparticles with dual functional properties: In vivo imaging and cancer chemotherapy - Abstract October 24, 2012

Basal and regulatory promoter studies of the AKR1C3 gene in relation to prostate cancer - Abstract October 24, 2012

Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression - Abstract October 24, 2012

Page 267 of 346